Page 389 - The Case Lab Book

The House Committee on Oversight and Investigations in February 2016
who were looking into Turing and other drug companies' price increases.

(4) cited the following excerpts from the company's internal documents and
emails.

When Turing agreed to buy Daraprim, company officials went
into celebration mode:

"Very good. Nice work as usual. $1bn here we come." — Turing

Chairman Ron Tilles email dated May 27, 2015.

"I think it will be huge. We raised the price from $1,700 per
bottle to $75,000. ... So 5,000 paying bottles at the new price is
$375,000,000 - almost all of it is profit and I think we will get 3

years of that or more. Should be a very handsome investment
for all of us." – Martin Shkreli email dated Aug. 27, 2015.

"Another $7.2 million. Pow!" — Tina Ghorban, senior director of
business analytics, reacting to a purchase order for 96 bottles

at $75,000 a bottle, on Sept. 17. (4)

The US Centers for Disease Control and Prevention, estimated that about
one million people in the U.S. were infected annually with the parasite. In
their treatment patients typically take the drug, Daraprim, for several
weeks. The antibiotic is used by about 2,000 Americans each year.